# The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

> **NCT01743287** · PHASE4 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 234 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Imotun capsule
- **DRUG:** Imotun capsule placebo

## Key facts

- **NCT ID:** NCT01743287
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01743287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01743287, "The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01743287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*